> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Emergency Use Authorization Revoked on Ebola Test
- URL: https://www.fdaweb.com/emergency-use-authorization-revoked-on-ebola-test/
- Published: 2018-08-02T12:00:00.000Z
- Updated: 2026-09-15T00:23:34.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5142028

*Federal Register* notice: FDA has announced that it has revoked an Emergency Use Authorization issued to Zalgen Labs for the ReEBOV Antigen Rapid Test, intended for use in detecting the Ebola virus. The authorization was revoked 5/18 as requested by the company in March after performance validation data were unacceptable, according to the agency. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-08-02/pdf/2018-16537.pdf?ref=fdaweb.com).